96036-02-1 = 96036-03-2 反应条件:1.1 Catalysts: Palladium Solvents: Tetrahydrofuran,Water; 6 H,Rt 标题:Meropenem Bulk Drug,Preparation Method And Pharmaceutical Composition Containing Same 参考文献:China]
171890-81-6 = 96036-03-2 反应条件:1.1 Reagents: Trifluoroacetic Acid,P-Toluenesulfonic Acid Solvents: Dichloromethane; 1 H,Rt; 5 H,Rt 标题:Method For Preparing Meropenem From Carbapenem Bicyclic Nucleus And (2S,4S)-2-(Dimethylaminocarbonyl)-4-Mercapto-1-(P-Nitrobenzyloxycarbonyl)-1-Pyrrolidine 参考文献:China]
96036-02-1 = 96036-03-2 反应条件:1.1 Reagents: 1-Methylpyrrolidine Catalysts: Palladium (Carbon Supported Pd Catalyst) Solvents: Tetrahydrofuran,Water; 25 °C 标题:Continuous Reaction Device For Preparing Meropenem And Its Preparation Method 参考文献:China]
96036-02-1 = 96036-03-2 反应条件:1.1 Reagents: 4-Methylaniline,Hydrogen Catalysts: Platinum; 41 Min,18 Bar,25 °C 标题:Process For The Deprotection Of A Carbapenem By Heterogeneous Catalytic Hydrogenation With Hydrogen In The Presence Of An Organic Amine 参考文献:World Intellectual Property Organization]
936226-35-6 = 96036-03-2 反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Tetrahydrofuran,Water; 90 S,1.4 Mpa,80 °C 标题:Method For Preparing Pharmaceutical Meropenem And Intermediate 10,11-Dihydro-5H-Dibenzo[b,F]Azepine By Continuous Solid-Liquid-Gas Three-Phase Reaction 参考文献:China]
96036-02-1 = 96036-03-2 反应条件:1.1 Reagents: Morpholine,Hydrogen Catalysts: Palladium Dihydroxide Solvents: Tetrahydrofuran,Water; Ph 7; 6 H,Ph 7,5 Kg/cm2,Rt1.2 Solvents: Acetone,Water; Overnight,0 - 5 °C 标题:Method For The Preparation Of Carbapenem Compound 参考文献:Korea
1: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Available from http://www.ncbi.nlm.nih.gov/books/NBK547861/ Review. doi: 10.1080/14787210.2018.1542300. Epub 2018 Nov 5. Review. doi: 10.2147/IDR.S150447. eCollection 2018. Review. 5: Wu G, Cheon E. Meropenem-vaborbactam for the treatment of complicated urinary tract infections including acute pyelonephritis. Expert Opin Pharmacother. 2018 Sep;19(13):1495-1502. doi: 10.1080/14656566.2018.1512586. Epub 2018 Aug 30. Review. doi: 10.1007/s40265-018-0966-7. Review. Erratum in: Drugs. 2018 Sep;78(13):1383. 7: Burgos RM, Biagi MJ, Rodvold KA, Danziger LH. Pharmacokinetic evaluation of meropenem and vaborbactam for the treatment of urinary tract infection. Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):1007-1021. doi: 10.1080/17425255.2018.1511702. Epub 2018 Sep 19. Review. doi: 10.1371/journal.pone.0201667. eCollection 2018. Review.
合成参考文献
参考文献:10.1128/aac.00023-13 摘要:Solapure S, Dinesh N, Shandil R, Ramachandran V, Sharma S, Bhattacharjee D, Ganguly S, Reddy J, Ahuja V, Panduga V, Parab M, Vishwas KG, Kumar N, Balganesh M, Balasubramanian V. In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2013 Jun;57(6):2506–10. doi: 10.1128/aac.00023-13.